IACC Full Committee Meeting


Date:	July 15, 2009
Time:	8:30 a.m. to 4:00 p.m. ET
Agenda:	In the morning, the IACC is hosting a joint meeting with the National Vaccine Advisory Committee (NVAC) Vaccine Safety Working Group to discuss vaccine safety and autism. Other agenda items include presentations on the NIH Autism Centers of Excellence and the National Database for Autism Research (NDAR), and discussion of services-related activities and analysis of the autism research portfolio.
Place:	In Person: The Ronald Reagan Building and International Trade Center The Polaris Room (Overflow: The Oceanic Room) 1300 Pennsylvania Avenue, NW Washington, DC 20004 In Person Registration: http://www.acclaroresearch.com/oarc/iacc_nvac7-15-09 Videocast: http://videocast.nih.gov/ To access the conference call: USA/Canada Phone Number: 888-455-2920 International Phone Number: 212-287-1838 Access code: 3132846
Contact Person:	Ms. Lina Perez Office of Autism Research Coordination National Institute of Mental Health, NIH 6001 Executive Boulevard, NSC Room 8185a Rockville, MD 20892-9669 Phone: 301-443-6040 IACCPublicInquiries@mail.nih.gov
Please Note:	Any member of the public interested in presenting oral comments to the Committee(s) must notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations must submit a letter of intent, a brief description of the organization represented, and a written/electronic copy of the oral presentation/statement at least 24 hours in advance of the meeting. A printed/ electronic copy of the comment/statement provided by the deadline is required prior to the oral presentation; the document will become a part of the public record. Only one representative of an organization will be allowed to present oral comments and presentations will be limited to three to five minutes per speaker, depending on number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in order of the date and time when their request to speak is received, along with the required written statement submitted at least 24 hours in advance of the meeting. In addition, any interested person may submit written comments to the IACC and/or the NVAC prior to the meeting by sending the statement to the Contact Person listed on this notice at least 24 hours in advance of the meeting. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. All written statements received by the deadline for both oral and written public comment will be provided to the IACC (and the NVAC, if appropriate) for their consideration. Information about the IACC and a registration link for this meeting are available on the IACC website.